PHARMACEUTICAL COMPOSITION OF THE INHALATION TYPE FOR THE TREATMENT OF PARKINSON DISEASE AND PREPARATION METHOD THEREFOR

摘要

The present invention provides an inhalation type pharmaceutical composition for Parkinson's disease comprising a first gas and a nebulized drug. The first gas includes hydrogen. The gas volume concentration of hydrogen in the inhalation type pharmaceutical composition is between 2 to 96%. The nebulized drug is levodopa, sinemet, atropine sulfate, scopolamine, a dopamine agonist, bromocriptine mesilate, selegiline, carbidopa, entacapone, or a combination thereof. The inhalation-type pharmaceutical composition of the present invention can provide the convenience of receiving the drug and removing harmful radicals in the body of the patient through the use of hydrogen, while also enhancing the absorption efficiency of the drug to the patient through the use of an atomized drug. Therefore, the present invention can provide a treatment for Parkinson's Disease that combines the convenience of taking the drug and also better healing effects in the user.